Publication | Closed Access

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

Hematological MalignancyCell TherapyTransplantationMarrow TransplantationInfused LymphocytesStem Cell TransplantationHematologyImmunologyAutoimmunityMultiple MyelomaBlood TransplantationImmunotherapyMedicineCell TransplantationClinical Outcome